The Effect of Recombinant Human Growth Hormone Therapy on Left-Ventricular Chamber Size and Function in Children With Growth Hormone Deficiency

ESEN I., CETIN I., DEMIREL F., Ekici F.

PEDIATRIC CARDIOLOGY, cilt.34, sa.8, ss.1854-1859, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 8
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s00246-013-0727-z
  • Dergi Adı: PEDIATRIC CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1854-1859
  • Anahtar Kelimeler: Recombinant human growth hormone, Left ventricle, Heart, Echocardiography, Children, Growth hormone deficiency, CARDIOVASCULAR RISK-FACTORS, GH REPLACEMENT THERAPY, CARDIAC-PERFORMANCE, TURKISH CHILDREN, TISSUE DOPPLER, ADULT PATIENTS, MASS, CHILDHOOD, HEART, ECHOCARDIOGRAPHY
  • Akdeniz Üniversitesi Adresli: Hayır

Özet

This study was designed to assess the effect of recombinant human growth hormone (rhGH) therapy on left-ventricular (LV) chamber size and function in children with idiopathic isolated growth hormone deficiency (GHD) using conventional echocardiography and tissue Doppler imaging (TDI). Thirty patients (19 boys and 11 girls) with idiopathic isolated GHD were followed-up for 12 months. Mean age of patients was 11.0 +/- A 2.6 years (range 6.3-15.5). At baseline and at 3, 6, and 12 months of treatment, the structure of the left ventricle was assessed by conventional echocardiography and myocardial rates and time intervals by TDI. There was a significant increase in LV mass (LVM) compared with pretreatment values. Like LVM, relative wall thickness (RWT) was also increased significantly. The significant increase in LVM indexed to body surface area and RWT became apparent at month 3 of treatment with a significant increase in LVM indexed to height(2.7) at treatment month 6. Normalized LVM increased as early month 3 of treatment, and a steady increase was observed until month 12. However, no patient had LVM > +2 standard deviation scores at month 12 of treatment. No significant differences were observed in functional parameters of the left ventricle and the interventricular septum. The results of this study showed that rhGH therapy causes an increase in myocardial mass without changing the geometry or function of the myocardium. Therefore, the increase in myocardial mass appears to be concentric, thus causing remodeling instead of hypertrophy.